Skip to content

Overactive Bladder (OAB) Drink Advice Study

Prospective Intervention Study of Drink Advice in Overactive Bladder Syndrome (OAB)

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00982241
Enrollment
0
Registered
2009-09-23
Start date
2009-07-31
Completion date
Unknown
Last updated
2012-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder Syndrome

Keywords

OAB, urine, osmolality, urge, fluid intake, PPIUS, urge score, bladder

Brief summary

The researchers want to investigate how fluid intake influences the symptoms of OAB. The researchers will recruit 45 patients with OAB and randomize them (blind) in 3 groups (low/normal/high fluid intake). Patients will follow this drink pattern for 2-5 days, while filling in an standard micturation diary for 2 days. This micturation diary is coupled to: collection of multiple urine samples, urine pH measurements, and a Perception of Intensity of Urgency Scale (PPIUS) scoring table. All this is collected by the patients themselves. Urine samples will be analysed for osmolality by the clinical chemistry department.

Interventions

DIETARY_SUPPLEMENTwater

drinking water / normal dietary fluids for oral intake

Sponsors

Radboud University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* OAB patients

Exclusion criteria

* benign prostatic hyperplasia * neurogenic detrusor overactivity * urine tract infection * anticholinergics * intravesical botulin toxin * cardiac failure * renal insufficiency * sacral neurostimulation * percutaneous neurostimulation

Design outcomes

Primary

MeasureTime frame
urine osmolality2 days
PPIUS urge-score2 days

Secondary

MeasureTime frame
urine pH2 days
PPIUS urge score2 days

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026